{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:20:07Z","timestamp":1776673207684,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Health Industry Development Institute funded by the Ministry of Health & Welfare, Republic of Korea","award":["RS-2022-KH129480"],"award-info":[{"award-number":["RS-2022-KH129480"]}]},{"name":"Samsung Medical Center Grant","award":["SMO1250391"],"award-info":[{"award-number":["SMO1250391"]}]},{"name":"Samsung Medical Center Grant","award":["SMO1264024"],"award-info":[{"award-number":["SMO1264024"]}]},{"name":"the Korea Health Technology R&D Project through the Korea Health Industry Development Institute","award":["RS-2022-KH127216"],"award-info":[{"award-number":["RS-2022-KH127216"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-04958-x","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:25:50Z","timestamp":1773249950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intracerebroventricular human mesenchymal stem cells induce MMP9-driven transient inflammation in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","clinical-trial-number":[{"clinical-trial-number":"nct02054208","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Su Hyeon","family":"Myeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Jin","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Wook","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"10","key":"4958_CR1","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-beta Pathway in Alzheimer\u2019s Disease. Mol Psychiatry. 2021;26(10):5481\u2013503.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4958_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211.","journal-title":"Signal Transduct Target Ther"},{"issue":"10510","key":"4958_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","volume":"406","author":"GB Frisoni","year":"2025","unstructured":"Frisoni GB, Hansson O, Nichols E, Garibotto V, Schindler SE, van der Flier WM, et al. New landscape of the diagnosis of Alzheimer\u2019s disease. Lancet. 2025;406(10510):1389\u2013407.","journal-title":"Lancet"},{"issue":"1","key":"4958_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","volume":"30","author":"LK Huang","year":"2023","unstructured":"Huang LK, Kuan YC, Lin HW, Hu CJ. Clinical trials of new drugs for Alzheimer disease: a 2020\u20132023 update. J Biomed Sci. 2023;30(1):83.","journal-title":"J Biomed Sci"},{"issue":"7","key":"4958_CR5","first-page":"524","volume":"332","author":"EFDA Harris","year":"2024","unstructured":"Harris EFDA. Green-lights second Alzheimer drug. Donanemab JAMA. 2024;332(7):524.","journal-title":"Donanemab JAMA"},{"key":"4958_CR6","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/bmj.p1580","volume":"382","author":"E Mahase","year":"2023","unstructured":"Mahase E. Alzheimer\u2019s disease: Lecanemab gets full FDA approval and black box safety warning. BMJ. 2023;382:1580.","journal-title":"BMJ"},{"issue":"1","key":"4958_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13287-022-02985-y","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Gao J, Liang Z, Gao C, Niu Q, Wu F, et al. Mesenchymal stem cells and their microenvironment. Stem Cell Res Ther. 2022;13(1):429.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4958_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han X, Liao R, Li X, Zhang C, Huo S, Qin L, et al. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther. 2025;10(1):262.","journal-title":"Signal Transduct Target Ther"},{"key":"4958_CR9","doi-asserted-by":"publisher","first-page":"9929128","DOI":"10.1155\/2021\/9929128","volume":"2021","author":"Y Li","year":"2021","unstructured":"Li Y, Zhong W, Tang X. Strategies to Improve the efficiency of transplantation with mesenchymal stem cells for the treatment of ischemic stroke: a review of recent progress. Stem Cells Int. 2021;2021:9929128.","journal-title":"Stem Cells Int"},{"key":"4958_CR10","doi-asserted-by":"crossref","unstructured":"Yarygin KN, Namestnikova DD, Sukhinich KK, Gubskiy IL, Majouga AG, Kholodenko IV. Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier? Cells. 2021;10(11).","DOI":"10.3390\/cells10112997"},{"key":"4958_CR11","doi-asserted-by":"publisher","first-page":"1011225","DOI":"10.3389\/fnmol.2022.1011225","volume":"15","author":"S Regmi","year":"2022","unstructured":"Regmi S, Liu DD, Shen M, Kevadiya BD, Ganguly A, Primavera R, et al. Mesenchymal stromal cells for the treatment of Alzheimer\u2019s disease: strategies and limitations. Front Mol Neurosci. 2022;15:1011225.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"4958_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-023-03264-0","volume":"14","author":"M Ghasemi","year":"2023","unstructured":"Ghasemi M, Roshandel E, Mohammadian M, Farhadihosseinabadi B, Akbarzadehlaleh P, Shamsasenjan K. Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials. Stem Cell Res Ther. 2023;14(1):122.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4958_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G, Brandi E, Vitola PL, Grandi F, Ferrara G, Pischiutta F, et al. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ. 2021;28(1):203\u201318.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4958_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","volume":"13","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, et al. Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer\u2019s disease dementia: a phase I clinical trial. Alzheimers Res Ther. 2021;13(1):154.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"4958_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1055\/s-0043-1777087","volume":"10","author":"OD Oyebode","year":"2023","unstructured":"Oyebode OD, Tulay P. Mesenchymal stem cells applications in Alzheimer\u2019s disease. Glob Med Genet. 2023;10(4):382\u20137.","journal-title":"Glob Med Genet"},{"issue":"8","key":"4958_CR16","doi-asserted-by":"publisher","first-page":"107717","DOI":"10.4252\/wjsc.v17.i8.107717","volume":"17","author":"CX Cui","year":"2025","unstructured":"Cui CX, Shao XN, Li YY, Qiao L, Lin JT, Guan LH. Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases. World J Stem Cells. 2025;17(8):107717.","journal-title":"World J Stem Cells"},{"key":"4958_CR17","doi-asserted-by":"publisher","first-page":"117405","DOI":"10.1016\/j.lfs.2020.117405","volume":"246","author":"L Zhang","year":"2020","unstructured":"Zhang L, Dong ZF, Zhang JY. Immunomodulatory role of mesenchymal stem cells in Alzheimer\u2019s disease. Life Sci. 2020;246:117405.","journal-title":"Life Sci"},{"issue":"1","key":"4958_CR18","doi-asserted-by":"publisher","first-page":"10772","DOI":"10.1038\/s41598-020-67460-1","volume":"10","author":"M Nakano","year":"2020","unstructured":"Nakano M, Kubota K, Kobayashi E, Chikenji TS, Saito Y, Konari N, et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer\u2019s disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10(1):10772.","journal-title":"Sci Rep"},{"key":"4958_CR19","doi-asserted-by":"crossref","unstructured":"Matsuoka T, Itohara T, Hara Y, Kobayashi N. Systematic Intravenous Administration of Autologous Mesenchymal Stem Cells Is Safe. J Clin Med. 2024;13(23).","DOI":"10.3390\/jcm13237460"},{"issue":"1","key":"4958_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41418-020-0592-2","volume":"28","author":"G Santamaria","year":"2021","unstructured":"Santamaria G, Brandi E, Vitola P, Grandi F, Ferrara G, Pischiutta F, et al. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer\u2019s mice. Cell Death Differ. 2021;28(1):203\u201318.","journal-title":"Cell Death Differ"},{"key":"4958_CR21","doi-asserted-by":"publisher","first-page":"9886877","DOI":"10.1155\/2021\/9886877","volume":"2021","author":"SJ Chung","year":"2021","unstructured":"Chung SJ, Lee TY, Lee YH, Baik K, Jung JH, Yoo HS, et al. Phase I Trial of intra-arterial administration of autologous bone marrow-derived mesenchymal stem cells in patients with multiple system atrophy. Stem Cells Int. 2021;2021:9886877.","journal-title":"Stem Cells Int"},{"key":"4958_CR22","doi-asserted-by":"crossref","unstructured":"Kim H, Na DL, Lee NK, Kim AR, Lee S, Jang H. Intrathecal Injection in A Rat Model: A Potential Route to Deliver Human Wharton\u2019s Jelly-Derived Mesenchymal Stem Cells into the Brain. Int J Mol Sci. 2020;21(4).","DOI":"10.3390\/ijms21041272"},{"key":"4958_CR23","doi-asserted-by":"crossref","unstructured":"Hwang JW, Lee NK, Yang JH, Son HJ, Bang SI, Chang JW et al. A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain. Int J Mol Sci. 2020;21(9).","DOI":"10.3390\/ijms21093052"},{"issue":"12","key":"4958_CR24","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","volume":"30","author":"MA Leone","year":"2023","unstructured":"Leone MA, Gelati M, Profico DC, Gobbi C, Pravata E, Copetti M, et al. Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell. 2023;30(12):1597\u2013609. e8.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"4958_CR25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/sctm.19-0327","volume":"9","author":"M Losurdo","year":"2020","unstructured":"Losurdo M, Pedrazzoli M, D\u2019Agostino C, Elia CA, Massenzio F, Lonati E, et al. Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer\u2019s disease. Stem Cells Transl Med. 2020;9(9):1068\u201384.","journal-title":"Stem Cells Transl Med"},{"issue":"19","key":"4958_CR26","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.7150\/thno.103596","volume":"14","author":"D Peng","year":"2024","unstructured":"Peng D, Liu T, Lu H, Zhang L, Chen H, Huang Y, et al. Intranasal delivery of engineered extracellular vesicles loaded with miR-206-3p antagomir ameliorates Alzheimer\u2019s disease phenotypes. Theranostics. 2024;14(19):7623\u201344.","journal-title":"Theranostics"},{"issue":"4","key":"4958_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.12779\/dnd.2025.24.4.272","volume":"24","author":"NK Lee","year":"2025","unstructured":"Lee NK, Jang H, Choi Y, Hwangbo S, Lee S, Lee JI, et al. Mesenchymal stem cells with adjuvant dexamethasone in patients with alzheimer\u2019s disease: a phase iia trial. Dement Neurocogn Disord. 2025;24(4):272\u201385.","journal-title":"Dement Neurocogn Disord"},{"key":"4958_CR28","doi-asserted-by":"publisher","first-page":"117537","DOI":"10.1016\/j.biopha.2024.117537","volume":"180","author":"Y Li","year":"2024","unstructured":"Li Y, Jin M, Guo D, Shen S, Lu K, Pan R, et al. Unveiling the immunogenicity of allogeneic mesenchymal stromal cells: challenges and strategies for enhanced therapeutic efficacy. Biomed Pharmacother. 2024;180:117537.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"4958_CR29","doi-asserted-by":"publisher","first-page":"e13267","DOI":"10.1111\/sji.13267","volume":"97","author":"W Chen","year":"2023","unstructured":"Chen W, Lv L, Chen N, Cui E. Immunogenicity of mesenchymal stromal\/stem cells. Scand J Immunol. 2023;97(6):e13267.","journal-title":"Scand J Immunol"},{"issue":"3","key":"4958_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"key":"4958_CR31","doi-asserted-by":"crossref","unstructured":"Myeong SH, Kim H, Lee NK, Hwang JW, Kim HJ, Jang H et al. Intracerebroventricular Administration of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Induces Transient Inflammation in a Transgenic Mouse Model and Patients with Alzheimer\u2019s Disease. Biomedicines. 2022;10(3).","DOI":"10.3390\/biomedicines10030563"},{"key":"4958_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863.","journal-title":"Front Psychol"},{"key":"4958_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1742-2094-8-106","volume":"8","author":"F Takata","year":"2011","unstructured":"Takata F, Dohgu S, Matsumoto J, Takahashi H, Machida T, WakigawaT, et al. Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-alpha, releasing matrix metalloproteinase-9 and migrating in vitro. J Neuroinflammation. 2011;8:106.","journal-title":"J Neuroinflammation"},{"key":"4958_CR34","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","volume":"11","author":"ME Bianchi","year":"2020","unstructured":"Bianchi ME, Mezzapelle R. The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration. Front Immunol. 2020;11:2109.","journal-title":"Front Immunol"},{"issue":"48","key":"4958_CR35","doi-asserted-by":"publisher","first-page":"22337","DOI":"10.1039\/D4NR03159H","volume":"16","author":"A Russo","year":"2024","unstructured":"Russo A, Maiorano G, Cortese B, D\u2019Amone S, Invidia A, Quattrini A, et al. Optimizing TDP-43 silencing with siRNA-loaded polymeric nanovectors in neuronal cells for therapeutic applications: balancing knockdown and function. Nanoscale. 2024;16(48):22337\u201349.","journal-title":"Nanoscale"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04958-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:13:21Z","timestamp":1776669201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04958-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4958"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04958-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. For the collection of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs), the project titled \u201cProvision and research use of hUCB-MSCs\u201d was approved by the Institutional Review Board (IRB) of MEDIPOST Co., Ltd. (approval number: MP-2014-10; approval date: October 2014). Written informed consent was obtained from all maternal donors prior to sample collection. This consent authorized the use of the cells for research purpose in accordance with regulatory approval by Ministry of Health and Welfare of the Republic of Korea. The clinical trial titled \u201cSafety and Exploratory Efficacy Study of NEUROSTEM\n                      \u00ae\n                      Versus Placebo in Patients With Alzheimer\u2019s Disease\u201d was approved by Korea Ministry of Food and Drug Safety (MFDS) and IRB of Samsung Medical Center (approval number: 2013-09-076; approval date: December 9, 2013) and was registered at ClinicalTrials.gov as NCT02054208. The CSF analysis project for Phase IIa participants titled \u201cIdentification of Biomarkers to Evaluate the Effectiveness of Stem Cell Treatment for Alzheimer\u2019s Disease\u201d was also approved by IRB of Samsung Medical Center (approval number: 2017\u201304\u2013025; approval date: June 20, 2017). Written informed consent was obtained from all participants and their caregivers. For the animal studies, the project titled \u201cIntracerebroventricular administration of MSCs induces transient inflammation in mouse brain\u201d was conducted with the approval of the Institutional Animal Care and Use Committee (IACUC) of the Research Institute for Future Medicine at Samsung Medical Center (approval number: 20170223001; approval date: March 15, 2017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors disclose the following potential conflicts of interest: SJC is currently employed by MEDIPOST Co., Ltd. (Republic of Korea). MSCs were supplied by MEDIPOST Co., Ltd. MEDIPOST did not play any additional role in data collection, analysis, the decision to publish, or the preparation of the manuscript. All other authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}